Rabeprazole Sodium
NDC 62135-503, Rabeprazole Sodium, tablet, delayed release, from Chartwell RX, LLC.
- Product NDC
- 62135-503
- Status
- Listed
- Labeler
- Chartwell RX, LLC
- Dosage form
- TABLET, DELAYED RELEASE
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA090678
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/62135-503 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- RABEPRAZOLE SODIUM20 mg/1
Pharmacologic classes
Proton Pump Inhibitor [EPC]; Proton Pump Inhibitors [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 62135-503-30 | 62135050330 | 30 TABLET, DELAYED RELEASE in 1 BOTTLE (62135-503-30) |
| 62135-503-90 | 62135050390 | 90 TABLET, DELAYED RELEASE in 1 BOTTLE (62135-503-90) |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/c5c43222-d167-4152-b5c7-84b55920a7ceNADAC price for package 62135050330
GET /v1/drugs/nadac/62135050330
Use it
Look up 62135-503 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/62135-503 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 62135-503. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.